rs2236277

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004568.6(SERPINB6):​c.54G>A​(p.Thr18Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.317 in 1,613,822 control chromosomes in the GnomAD database, including 83,768 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 7294 hom., cov: 32)
Exomes 𝑓: 0.32 ( 76474 hom. )

Consequence

SERPINB6
NM_004568.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.58

Publications

30 publications found
Variant links:
Genes affected
SERPINB6 (HGNC:8950): (serpin family B member 6) The protein encoded by this gene is a member of the serpin (serine proteinase inhibitor) superfamily, and ovalbumin(ov)-serpin subfamily. It was originally discovered as a placental thrombin inhibitor. The mouse homolog was found to be expressed in the hair cells of the inner ear. Mutations in this gene are associated with nonsyndromic progressive hearing loss, suggesting that this serpin plays an important role in the inner ear in the protection against leakage of lysosomal content during stress, and that loss of this protection results in cell death and sensorineural hearing loss. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2010]
SERPINB6 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 91
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P, Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.015).
BP6
Variant 6-2959279-C-T is Benign according to our data. Variant chr6-2959279-C-T is described in ClinVar as Benign. ClinVar VariationId is 44135.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.58 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.484 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SERPINB6NM_004568.6 linkc.54G>A p.Thr18Thr synonymous_variant Exon 2 of 7 ENST00000380539.7 NP_004559.4 P35237A0A024QZX3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SERPINB6ENST00000380539.7 linkc.54G>A p.Thr18Thr synonymous_variant Exon 2 of 7 3 NM_004568.6 ENSP00000369912.2 P35237

Frequencies

GnomAD3 genomes
AF:
0.296
AC:
44912
AN:
151954
Hom.:
7291
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.183
Gnomad AMI
AF:
0.363
Gnomad AMR
AF:
0.388
Gnomad ASJ
AF:
0.373
Gnomad EAS
AF:
0.500
Gnomad SAS
AF:
0.356
Gnomad FIN
AF:
0.277
Gnomad MID
AF:
0.377
Gnomad NFE
AF:
0.320
Gnomad OTH
AF:
0.338
GnomAD2 exomes
AF:
0.349
AC:
87707
AN:
251466
AF XY:
0.344
show subpopulations
Gnomad AFR exome
AF:
0.174
Gnomad AMR exome
AF:
0.495
Gnomad ASJ exome
AF:
0.380
Gnomad EAS exome
AF:
0.501
Gnomad FIN exome
AF:
0.278
Gnomad NFE exome
AF:
0.319
Gnomad OTH exome
AF:
0.346
GnomAD4 exome
AF:
0.319
AC:
466494
AN:
1461752
Hom.:
76474
Cov.:
39
AF XY:
0.319
AC XY:
232322
AN XY:
727186
show subpopulations
African (AFR)
AF:
0.168
AC:
5626
AN:
33478
American (AMR)
AF:
0.481
AC:
21496
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.375
AC:
9790
AN:
26136
East Asian (EAS)
AF:
0.498
AC:
19765
AN:
39700
South Asian (SAS)
AF:
0.334
AC:
28789
AN:
86254
European-Finnish (FIN)
AF:
0.282
AC:
15085
AN:
53404
Middle Eastern (MID)
AF:
0.317
AC:
1828
AN:
5768
European-Non Finnish (NFE)
AF:
0.310
AC:
344659
AN:
1111902
Other (OTH)
AF:
0.322
AC:
19456
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
18207
36414
54621
72828
91035
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11384
22768
34152
45536
56920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.295
AC:
44914
AN:
152070
Hom.:
7294
Cov.:
32
AF XY:
0.296
AC XY:
21996
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.182
AC:
7559
AN:
41486
American (AMR)
AF:
0.388
AC:
5937
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.373
AC:
1294
AN:
3470
East Asian (EAS)
AF:
0.500
AC:
2584
AN:
5172
South Asian (SAS)
AF:
0.355
AC:
1712
AN:
4816
European-Finnish (FIN)
AF:
0.277
AC:
2924
AN:
10550
Middle Eastern (MID)
AF:
0.377
AC:
110
AN:
292
European-Non Finnish (NFE)
AF:
0.320
AC:
21753
AN:
67978
Other (OTH)
AF:
0.336
AC:
710
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1590
3180
4770
6360
7950
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
460
920
1380
1840
2300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.323
Hom.:
17977
Bravo
AF:
0.303
Asia WGS
AF:
0.387
AC:
1342
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Thr18Thr in Exon 03 of SERPINB6: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence, and has been identified in 32.1% (2253/7020) of European American chromosomes from a broad population by the NHLBI Exome Sequ encing Project (http://evs.gs.washington.edu/EVS; dbSNP rs2236277). -

May 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Autosomal recessive nonsyndromic hearing loss 91 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
8.1
DANN
Benign
0.62
PhyloP100
-1.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2236277; hg19: chr6-2959513; COSMIC: COSV59565112; COSMIC: COSV59565112; API